Parameter | Whole group (n = 150) | CRSwNP with asthma (n = 80) | CRSwNP without asthma (n = 70) | P value |
---|---|---|---|---|
Female, n (%) | 55 (36.7) | 39 (48.8) | 16 (22.9) | 0.001* |
Age, years | 48.0 (38.0, 56.0) | 48.0 (35.3, 55.0) | 48.5 (41.0, 59.0) | 0.239 |
BMI, kg/m2 | 24.2 (22.2, 27.1) | 23.5 (21.6, 26.2) | 25.2 (23.1, 27.7) | 0.019* |
Overweight (BMI = 25 ~ 29.9 kg/m2), n (%) | 49 (32.7%) | 21(26.3) | 28 (40.0) | 0.073 |
Obesity (BMI ≥ 30 kg/m2), n (%) | 14 (9.3%) | 7(8.8%) | 7 (10%) | 0.793 |
Smokers, n (%) | 44 (29.3) | 21 (26.3) | 23 (32.9) | 0.375 |
Pack-years smoked | 15.0 (9.4, 30.0) | 10.0 (7.5, 25.0) | 20.0 (10.0, 40.0) | 0.110 |
NSAIDs hypersensitivity, n (%) | 19 (12.7) | 17 (21.3) | 2 (2.9) | 0.001* |
History of allergic rhinitis, n (%) | 44 (29.3) | 31 (38.8) | 13 (18.6) | 0.007* |
History of urticaria, n (%) | 34 (22.7) | 23 (28.7) | 11 (15.7) | 0.057 |
History of eczema, n (%) | 6 (4.0) | 4 (5.0) | 2 (2.9) | 0.802 |
Nasal obstruction duration, years | 4.0 (1.0, 10.0) | 4.0 (2.0, 8.0) | 3.0 (1.0, 10.0) | 0.549 |
Blood eosinophil percentage, % | 5.0 (3.1, 7.7) | 6.1 (4.1, 9.2) | 4.5 (2.0, 6.2) | 0.001* |
Blood eosinophil count, × 109/L | 0.3 (0.2, 0.5) | 0.4 (0.3, 0.6) | 0.3 (0.1, 0.4) | < 0.001* |
Positive eosinophil of nasal secretion, n (%) | 47 (31.3) | 31 (38.8) | 16 (22.9) | 0.036* |
Serum T-IgE, kU/L | 103.5 (38.8, 244.0) | 140.0 (73.0, 310.8) | 54.2 (30.3, 131.0) | < 0.001* |
Atopy, n (%) | 58 (38.7) | 33 (41.3) | 25 (35.7) | 0.487 |
Dust mite sensitivity, n (%) | 43 (28.7) | 27 (33.8) | 16 (22.9) | 0.141 |
Pollen sensitivity, n (%) | 16 (10.7) | 7 (8.8) | 9 (12.9) | 0.416 |
Animal sensitivity, n (%) | 5 (3.3) | 4 (5.0) | 1 (1.4) | 0.447 |
Cockroach sensitivity, n (%) | 8 (5.3) | 3 (3.8) | 5 (7.1) | 0.577 |
Mold sensitivity, n (%) | 3 (2.0) | 3 (3.8) | 0 (0.0) | 0.293 |
Food sensitivity, n (%) | 21 (14.0) | 11 (13.8) | 10 (14.3) | 0.925 |
FeNO, ppb | 27.0 (16.0, 48.0) | 35.0 (21.5, 56.8) | 20.5 (13.0, 29.0) | < 0.001* |